{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:56:18Z","timestamp":1786118178264,"version":"build-2736575974"},"reference-count":72,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,11,15]]},"DOI":"10.1097\/01.tp.0000237101.58974.43","type":"journal-article","created":{"date-parts":[[2006,11,10]],"date-time":"2006-11-10T06:12:09Z","timestamp":1163139129000},"page":"1153-1162","source":"Crossref","is-referenced-by-count":86,"title":["Conversion From Calcineurin Inhibitors to Sirolimus for Chronic Renal Allograft Dysfunction: A Systematic Review of the Evidence"],"prefix":"10.1097","volume":"82","author":[{"given":"Atul V.","family":"Mulay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Cockfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rod","family":"Stryker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Fergusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg A.","family":"Knoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210129","first-page":"s1","article-title":"US Renal Data System: Excerpts from the USRDS 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States.","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R2-8-20210129","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"R3-8-20210129","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ki.1996.307","article-title":"A study of the quality of life and cost-utility of renal transplantation.","volume":"50","author":"Laupacis","year":"1996","journal-title":"Kidney Int"},{"key":"R4-8-20210129","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1523-1755.2000.00816.x","article-title":"Long-term survival in renal transplant recipients with graft function.","volume":"57","author":"Ojo","year":"2000","journal-title":"Kidney Int"},{"key":"R5-8-20210129","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1111\/j.1523-1755.2005.09920.x","article-title":"Longitudinal analysis of chronic allograft nephropathy: clinicopathologic correlations.","author":"Chapman","year":"2005","journal-title":"Kidney Int"},{"key":"R6-8-20210129","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1034\/j.1600-6143.2002.21015.x","article-title":"Death after graft loss: an important late study endpoint in kidney transplantation.","volume":"2","author":"Kaplan","year":"2002","journal-title":"Am J Transplant"},{"key":"R7-8-20210129","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1111\/j.1600-6143.2005.00921.x","article-title":"Patient survival following renal transplant failure in Canada.","volume":"5","author":"Knoll","year":"2005","journal-title":"Am J Transplant"},{"key":"R9-8-20210129","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1681\/ASN.V101167","article-title":"Rethinking Chronic Allograft Nephropathy: The Concept of Accelerated Senescence.","volume":"10","author":"Halloran","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R10-8-20210129","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1111\/j.1523-1755.2005.09923.x","article-title":"Immunosuppressive treatment and progression of histologic lesions in kidney allografts.","author":"Morales","year":"2005","journal-title":"Kidney Int Suppl"},{"key":"R11-8-20210129","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy.","volume":"349","author":"Nankivell","year":"2003","journal-title":"N Engl J Med"},{"key":"R12-8-20210129","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1046\/j.1523-1755.1999.00611.x","article-title":"Chronic allograft nephropathy: An update.","volume":"56","author":"Paul","year":"1999","journal-title":"Kidney Int"},{"key":"R13-8-20210129","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"key":"R14-8-20210129","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0272-6386(00)70348-9","article-title":"Nephrotoxicity of immunosuppressive drugs: Long-term consequences and challenges for the future.","volume":"35","author":"de Mattos","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"R15-8-20210129","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1432-2277.2003.tb00277.x","article-title":"Pathogenesis of chronic allograft rejection.","volume":"16","author":"Joosten","year":"2003","journal-title":"Transplant Int"},{"issue":"4","key":"R16-8-20210129","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000079390","article-title":"Late calcineurin inhibitor withdrawal as a strategy to prevent graft loss in patients with suboptimal kidney transplant function.","volume":"24","author":"Weir","year":"2004","journal-title":"Am J Nephrol"},{"key":"R17-8-20210129","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1600-6143.2004.00404.x","article-title":"Withdrawal of Cyclosporine or Tacrolimus After Addition of Mycophenolate Mofetil in Patients With Chronic Allograft Nephropathy.","volume":"4","author":"Suwelack","year":"2004","journal-title":"Am J Transplant"},{"key":"R18-8-20210129","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ndt\/16.suppl_1.121","article-title":"Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation.","volume":"16","author":"Morales","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"R19-8-20210129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1523-1755.2001.00460.x","article-title":"Rapamycin in transplantation: A review of the evidence.","volume":"59","author":"Saunders","year":"2001","journal-title":"Kidney Int"},{"key":"R20-8-20210129","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1097\/00007890-200010270-00021","article-title":"Conversion to rapamycin immunosuppression in renal transplant recipients: report of an initial experience.","volume":"70","author":"Dominguez","year":"2000","journal-title":"Transplantation"},{"key":"R21-8-20210129","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1016\/S0041-1345(02)03679-5","article-title":"Sirolimus rescue treatment in calcineurin-inhibitor nephrotoxicity after kidney transplantation.","volume":"34","author":"Wyzgal","year":"2002","journal-title":"Transplant Proc"},{"key":"R22-8-20210129","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1681\/ASN.2005060635","article-title":"Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients.","volume":"16","author":"Stallone","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 1","key":"R24-8-20210129","first-page":"155","article-title":"A Randomized, open label, comparative evaluation of the safety and efficacy of conversion from calcineurin inhibitors to sirolimus versus continued use of calcineurin inhibitors in renal allograft recipients [Abstract].","volume":"18","author":"Schena","year":"2005","journal-title":"Transpl Int"},{"issue":"1","key":"R25-8-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"R26-8-20210129","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/j.1600-6143.2005.01055.x","article-title":"A Randomized Controlled Trial of Late Conversion from CNI-Based to Sirolimus-Based Immunosuppression Following Renal Transplantation.","volume":"5","author":"Watson","year":"2005","journal-title":"Am J Transplant"},{"key":"R27-8-20210129","first-page":"285","article-title":"Statistical methods for examining heterogeneity and combining results from several studies in meta- analysis.","author":"Deeks","year":"2001"},{"issue":"8","key":"R28-8-20210129","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E","article-title":"Two-sided confidence intervals for the single proportion: comparison of seven methods.","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat Med"},{"issue":"5","key":"R29-8-20210129","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/(SICI)1097-0258(19990315)18:5<557::AID-SIM53>3.0.CO;2-F","article-title":"Methods for combining rates from several studies.","volume":"18","author":"Zhou","year":"1999","journal-title":"Stat Med"},{"issue":"S5","key":"R30-8-20210129","first-page":"211","article-title":"Rapamycin substitution for calcineurin inhibitors in renal transplant recipients with chronic allograft nephropathy [Abstract].","volume":"3","author":"Amm","year":"2003","journal-title":"Am J Transplant"},{"key":"R31-8-20210129","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000079808","article-title":"Low-dose sirolimus in combination with mycophenolate mofetil improves kidney graft function late after renal transplantation and suggests pharmacokinetic interaction of both immunosuppressive drugs.","volume":"27","author":"Renders","year":"2004","journal-title":"Kidney Blood Press Res"},{"issue":"S8","key":"R32-8-20210129","first-page":"220","article-title":"Six month interim analysis of a phase III prospective, randomised study to compare conversion from calcineurin inhibitors to rapamycin in established renal allograft recipients with mild to moderate renal insufficiency [Abstract].","volume":"4","author":"Baboolal","year":"2004","journal-title":"Am J Transplant"},{"key":"R33-8-20210129","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/S0041-1345(03)00375-0","article-title":"Rapid conversion to sirolimus for chronic progressive deterioration of the renal function in kidney allograft recipients.","volume":"35","author":"Citterlo","year":"2003","journal-title":"Transplant Proc"},{"issue":"S5","key":"R34-8-20210129","first-page":"354","article-title":"A single center experience with sirolimus conversion therapy in renal allograft recipients [Abstract].","volume":"3","author":"Crowley","year":"2003","journal-title":"Am J Transplant"},{"key":"R35-8-20210129","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1016\/S0041-1345(01)02375-2","article-title":"Conversion to rapamycin in renal allograft recipients with biopsy-proven calcineurin inhibitor- induced nephrotoxicity.","volume":"33","author":"Diekmann","year":"2001","journal-title":"Transplant Proc"},{"key":"R36-8-20210129","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1111\/j.1600-6143.2004.00590.x","article-title":"Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction.","volume":"4","author":"Diekmann","year":"2004","journal-title":"Am J Transplant"},{"key":"R37-8-20210129","doi-asserted-by":"crossref","first-page":"131S","DOI":"10.1016\/S0041-1345(03)00240-9","article-title":"Conversion to sirolimus in solid organ transplantation: a single-center experience.","volume":"35","author":"Egidi","year":"2003","journal-title":"Transplant Proc"},{"issue":"S8","key":"R38-8-20210129","first-page":"266","article-title":"Determinants of long term preservation of renal function after conversion to sirolimus in patients with chronic allograft nephropathy [Abstract].","volume":"4","author":"Guasch","year":"2004","journal-title":"Am J Transplant"},{"issue":"S8","key":"R39-8-20210129","first-page":"433","article-title":"Nephrotic range proteinuria and other severe adverse events after conversion to sirolimus in renal transplantation: Is high exposure to sirolimus responsible? [Abstract].","volume":"4","author":"Hadaya","year":"2004","journal-title":"Am J Transplant"},{"issue":"S8","key":"R40-8-20210129","first-page":"161","article-title":"Proteinuria following switch from calcineurin inhibitors to sirolimus: A retrospective study [Abstract].","volume":"4","author":"Letavernier","year":"2004","journal-title":"Am J Transplant"},{"issue":"S8","key":"R41-8-20210129","first-page":"221","article-title":"Late conversion to sirolimus in a kidney transplant population: Is it worth? [Abstract].","volume":"4","author":"Lord","year":"2004","journal-title":"Am J Transplant"},{"issue":"S5","key":"R42-8-20210129","first-page":"217","article-title":"An open non comparative pilot study of renal function after conversion from cyclosporin (CsA) to sirolimus (SRL) in stable renal allograft recipients with mild to moderate renal insufficiency [Abstract].","volume":"3","author":"Paczek","year":"2003","journal-title":"Am J Transplant"},{"key":"R43-8-20210129","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1399-0012.2004.00314.x","article-title":"An open-label pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in established renal allograft recipients with moderate renal insufficiency.","volume":"19","author":"Peddi","year":"2005","journal-title":"Clin Transplant"},{"issue":"S8","key":"R44-8-20210129","first-page":"296","article-title":"Chronic allograft damage index (CADI)2 scoring at conversion from calcineurin inhibitors (CI) to sirolimus predicts renal outcome in kidney transplant recipients[Abstract].","volume":"4","author":"Sankaranarayanan","year":"2004","journal-title":"Am J Transplant"},{"issue":"S11","key":"R45-8-20210129","first-page":"554","article-title":"Late introduction of sirolimus introduces anemia of inflammatory state in renal transplant recipients. [Abstract].","volume":"5","author":"Thaunat","year":"2005","journal-title":"Am J Transplant"},{"key":"R46-8-20210129","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/01.TP.0000056639.74982.F9","article-title":"Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil.","volume":"75","author":"van Gelder","year":"2003","journal-title":"Transplantation"},{"issue":"S5","key":"R47-8-20210129","first-page":"336","article-title":"Can we change the progressive decay in graft function after the onset of chronic allograft nephropathy (CAN) in the recipients of kidney allografts? (preliminary results of the ongoing study) [Abstract].","volume":"3","author":"Wali","year":"2003","journal-title":"Am J Transplant"},{"key":"R48-8-20210129","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1399-0012.2004.00220.x","article-title":"Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.","volume":"18","author":"Sundberg","year":"2004","journal-title":"Clin Transplant"},{"issue":"S11","key":"R49-8-20210129","first-page":"376","article-title":"Conversion to and from sirolimus in renal and hepatic transplant recipients treated with calcineurin inhibitors:Effect on renal function.[Abstract].","volume":"5","author":"Moneim","year":"2005","journal-title":"Am J Transplant"},{"key":"R50-8-20210129","first-page":"414","article-title":"Sirolimus associated proteinuria. Study in kidney (KTx) and heart (HTx) recipients after calcineurin inhibitor (CNI) withdrawal and in KTX with sirolimus de novo immunosuppression [Abstract].","volume":"5","author":"Lacha","year":"2005","journal-title":"Am J Transplant"},{"issue":"S11","key":"R51-8-20210129","first-page":"497","article-title":"Switch of immunosuppression from calcineurin inhibitors (CNI) to sirolimus (SRL) in pediatric renal transplant recipients with CNI toxicity [Abstract].","volume":"5","author":"Hoecker","year":"2005","journal-title":"Am J Transplant"},{"issue":"S11","key":"R52-8-20210129","first-page":"519","article-title":"Evolution of proteinuria after conversion from calcineurin inhibitors (CNI) to sirolimus (SRL) in renal transplant patients. A multicenter study [Abstract].","volume":"5","author":"Ruiz","year":"2005","journal-title":"Am J Transplant"},{"key":"R53-8-20210129","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1399-0012.2005.00329.x","article-title":"Rapamycin in patients with chronic renal allograft dysfunction.","volume":"19","author":"Wu","year":"2005","journal-title":"Clin Transplant"},{"key":"R54-8-20210129","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1093\/ndt\/gfh957","article-title":"Long term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.","volume":"20","author":"Bumbea","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R55-8-20210129","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1016\/j.transproceed.2003.09.033","article-title":"Low-dose sirolimus in combination with mycophenolate in calcineurin inhibitor elimination: the Kuwaiti experience.","volume":"35","author":"Johny","year":"2003","journal-title":"Transplant Proc"},{"key":"R56-8-20210129","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1681\/ASN.V132536","article-title":"Open Randomized Trial Comparing Early Withdrawal of either Cyclosporine or Mycophenolate Mofetil in Stable Renal Transplant Recipients Initially Treated with a Triple Drug Regimen.","volume":"13","author":"Schnuelle","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R57-8-20210129","doi-asserted-by":"crossref","first-page":"52S","DOI":"10.1016\/S0041-1345(03)00244-6","article-title":"Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experience.","volume":"35","author":"Morelon","year":"2003","journal-title":"Transplant Proc"},{"key":"R58-8-20210129","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1432-2277.2004.tb00431.x","article-title":"Rapamycin-associated post-transplantation glomerulonephritis and its remission after reintroduction of calcineurin-inhibitor therapy.","volume":"17","author":"Dittrich","year":"2004","journal-title":"Transplant Int"},{"key":"R59-8-20210129","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1097\/01.TP.0000140868.88149.63","article-title":"Investigation of pediatric renal transplant recipients with heavy proteinuria after sirolimus rescue.","volume":"78","author":"Butani","year":"2004","journal-title":"Transplantation"},{"key":"R60-8-20210129","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/j.1600-6143.2005.01013.x","article-title":"Proteinuria developing after clinical islet transplantation resolves with sirolimus withdrawal and increased tacrolimus dosing.","volume":"5","author":"Senior","year":"2005","journal-title":"Am J Transplant"},{"key":"R61-8-20210129","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/ndt\/gfi266","article-title":"Conversion from calcineurin inhibitors to sirolimus in chronic allograft dysfunction: changes in glomerular haemodynamics and proteinuria.","volume":"21","author":"Saurina","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R62-8-20210129","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/ki.1988.38","article-title":"The long-term course of cyclosporine-associated chronic nephropathy.","volume":"33","author":"Myers","year":"1988","journal-title":"Kidney Int"},{"key":"R63-8-20210129","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1034\/j.1600-6143.2003.00078.x","article-title":"Sirolimus Prolongs Recovery from Delayed Graft Function After Cadaveric Renal Transplantation.","volume":"3","author":"McTaggart","year":"2003","journal-title":"Am J Transplant"},{"key":"R64-8-20210129","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/ndt\/gfh079","article-title":"Acute rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathies.","volume":"19","author":"Fervenza","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"R65-8-20210129","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00007890-200108150-00014","article-title":"Proteinuria after renal transplantation affects not only graft survival but also patient survival.","volume":"72","author":"Roodnat","year":"2001","journal-title":"Transplantation"},{"key":"R66-8-20210129","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1681\/ASN.V11101910","article-title":"A Meta-Analysis of Immunosuppression Withdrawal Trials in Renal Transplantation.","volume":"11","author":"Kasiske","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"R67-8-20210129","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/00007890-200109150-00007","article-title":"Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure.","volume":"72","author":"Johnson","year":"2001","journal-title":"Transplantation"},{"key":"R68-8-20210129","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/01.TP.0000074310.40484.94","article-title":"Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: incidence, risk factors, progression, and prognosis.","volume":"76","author":"Chueh","year":"2003","journal-title":"Transplantation"},{"key":"R69-8-20210129","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1034\/j.1399-0012.2003.00021.x","article-title":"Influence of hypercholesterolemia on patient and graft survival in recipients of kidney transplants.","volume":"17","author":"Booth","year":"2003","journal-title":"Clinical Transplant"},{"key":"R70-8-20210129","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1097\/00007890-200004270-00029","article-title":"Cholesterol as an independent predictor of outcome after renal transplantation.","volume":"69","author":"Roodnat","year":"2000","journal-title":"Transplantation"},{"key":"R71-8-20210129","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/S0085-2538(15)48744-7","article-title":"Risk factors for late kidney allograft failure.","volume":"62","author":"Ponticelli","year":"2002","journal-title":"Kidney International"},{"key":"R72-8-20210129","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1034\/j.1600-6143.2002.20610.x","article-title":"Effects of sirolimus on lipids in renal allograft recipients: an analysis using the Framingham risk model.","volume":"2","author":"Blum","year":"2002","journal-title":"Am J Transplant"},{"key":"R73-8-20210129","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/01.TP.0000184006.43152.8D","article-title":"Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies.","volume":"80","author":"Kauffman","year":"2005","journal-title":"Transplantation"},{"key":"R75-8-20210129","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1034\/j.1600-6143.2002.20301.x","article-title":"Call for revolution: A new approach to describing allograft deterioration.","volume":"2","author":"Halloran","year":"2002","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007890-200611150-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:24:14Z","timestamp":1786029854000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200611150-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,15]]},"references-count":72,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.tp.0000237101.58974.43","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11,15]]}}}